This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jain, M. Articles by Hauser, A. R. Search for Related Content PubMed PubMed Citation Articles by Jain, M. Articles by Hauser, A. R.

Type III Secretion Phenotypes of Pseudomonas aeruginosa Strains Change during Infection of Individuals with Cystic Fibrosis

Manu Jain,¹ Daniel Ramirez,² Roopa Seshadri,^3,4 Joanne F. Cullina,¹ Catherine A. Powers,⁵ Grant S. Schulert,^2, Maskit Bar-Meir,⁶ Christine L. Sullivan,⁴ Susanna A. McColley,⁵ and Alan R. Hauser^1,2*

Department of Medicine,¹ Department of Microbiology/Immunology,² Departments of Pediatrics and Preventive Medicine, Northwestern University,³ Child Health Research Program, Children's Memorial Institute for Education and Research,⁴ Division of Pulmonary and Critical Care Medicine,⁵ Division of Infectious Diseases, Children's Memorial Hospital, Chicago, Illinois⁶

Received 18 March 2004/ Returned for modification 14 June 2004/ Accepted 30 July 2004

Pseudomonas aeruginosa is a frequent cause of respiratory exacerbations in individuals with cystic fibrosis. An important virulence determinant of this pathogen is its type III protein secretion system. In this study, the type III secretion properties of 435 P. aeruginosa respiratory isolates from 56 chronically infected individuals with cystic fibrosis were investigated. Although it had been previously reported that 75 to 90% of P. aeruginosa isolates from patients with hospital-acquired pneumonia secreted type III proteins, only 12% of isolates from cystic fibrosis patients did so, with nearly all of these isolates secreting ExoS and ExoT but not ExoU. Despite the low overall prevalence of type III protein-secreting isolates, at least one secreting isolate was cultured from one-third of cystic fibrosis patients. Interestingly, the fraction of cystic fibrosis patient isolates capable of secreting type III proteins decreased with duration of infection. Although 90% of isolates from the environment, the presumed reservoir for the majority of P. aeruginosa strains that infect patients with cystic fibrosis, secreted type III proteins, only 49% of isolates from newly infected children, 18% of isolates from chronically infected children, and 4% of isolates from chronically infected adults with cystic fibrosis secreted these proteins. Within individual patients, isolates of clonal origin differed in their secretion phenotypes, indicating that as strains persisted in cystic fibrosis patient airways, their type III protein secretion properties changed. Together, these findings indicate that following infection of cystic fibrosis patient airways, P. aeruginosa strains gradually change from a type III protein secretion-positive phenotype to a secretion-negative phenotype.

Present address: University of Iowa, Iowa City, Iowa.

This article has been cited by other articles:

• Yang, L., Haagensen, J. A. J., Jelsbak, L., Johansen, H. K., Sternberg, C., Hoiby, N., Molin, S. (2008). In Situ Growth Rates and Biofilm Development of Pseudomonas aeruginosa Populations in Chronic Lung Infections. J. Bacteriol. 190: 2767-2776 [Abstract] [Full Text]  
• Miao, E. A., Ernst, R. K., Dors, M., Mao, D. P., Aderem, A. (2008). Pseudomonas aeruginosa activates caspase 1 through Ipaf. Proc. Natl. Acad. Sci. USA 105: 2562-2567 [Abstract] [Full Text]  
• Mulcahy, H., O'Callaghan, J., O'Grady, E. P., Macia, M. D., Borrell, N., Gomez, C., Casey, P. G., Hill, C., Adams, C., Gahan, C. G. M., Oliver, A., O'Gara, F. (2008). Pseudomonas aeruginosa RsmA Plays an Important Role during Murine Infection by Influencing Colonization, Virulence, Persistence, and Pulmonary Inflammation. Infect. Immun. 76: 632-638 [Abstract] [Full Text]  
• Tingpej, P., Smith, L., Rose, B., Zhu, H., Conibear, T., Al Nassafi, K., Manos, J., Elkins, M., Bye, P., Willcox, M., Bell, S., Wainwright, C., Harbour, C. (2007). Phenotypic Characterization of Clonal and Nonclonal Pseudomonas aeruginosa Strains Isolated from Lungs of Adults with Cystic Fibrosis. J. Clin. Microbiol. 45: 1697-1704 [Abstract] [Full Text]  
• Smith, L., Rose, B., Tingpej, P., Zhu, H., Conibear, T., Manos, J., Bye, P., Elkins, M., Willcox, M., Bell, S., Wainwright, C., Harbour, C. (2006). Protease IV production in Pseudomonas aeruginosa from the lungs of adults with cystic fibrosis.. J Med Microbiol 55: 1641-1644 [Abstract] [Full Text]  
• Nguyen, D., Singh, P. K. (2006). Evolving stealth: Genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections. Proc. Natl. Acad. Sci. USA 103: 8305-8306 [Full Text]  
• Aspedon, A., Palmer, K., Whiteley, M. (2006). Microarray Analysis of the Osmotic Stress Response in Pseudomonas aeruginosa.. J. Bacteriol. 188: 2721-2725 [Abstract] [Full Text]  
• Ventre, I., Goodman, A. L., Vallet-Gely, I., Vasseur, P., Soscia, C., Molin, S., Bleves, S., Lazdunski, A., Lory, S., Filloux, A. (2006). Multiple sensors control reciprocal expression of Pseudomonas aeruginosa regulatory RNA and virulence genes. Proc. Natl. Acad. Sci. USA 103: 171-176 [Abstract] [Full Text]  
• Shaver, C. M., Hauser, A. R. (2006). Interactions between effector proteins of the Pseudomonas aeruginosa type III secretion system do not significantly affect several measures of disease severity in mammals. Microbiology 152: 143-152 [Abstract] [Full Text]  
• Corech, R., Rao, A., Laxova, A., Moss, J., Rock, M. J., Li, Z., Kosorok, M. R., Splaingard, M. L., Farrell, P. M., Barbieri, J. T. (2005). Early Immune Response to the Components of the Type III System of Pseudomonas aeruginosa in Children with Cystic Fibrosis. J. Clin. Microbiol. 43: 3956-3962 [Abstract] [Full Text]  
• Foweraker, J. E., Laughton, C. R., Brown, D. F. J., Bilton, D. (2005). Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing. J Antimicrob Chemother 55: 921-927 [Abstract] [Full Text]